Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Voyager Therapeutics (VYGR) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to $2.4 million.

  • Voyager Therapeutics' Interest & Investment Income fell 4791.44% to $2.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.5 million, marking a year-over-year decrease of 2851.67%. This contributed to the annual value of $18.3 million for FY2024, which is 5636.89% up from last year.
  • Latest data reveals that Voyager Therapeutics reported Interest & Investment Income of $2.4 million as of Q3 2025, which was down 4791.44% from $2.8 million recorded in Q2 2025.
  • Over the past 5 years, Voyager Therapeutics' Interest & Investment Income peaked at $4.9 million during Q2 2024, and registered a low of -$643000.0 during Q4 2021.
  • In the last 5 years, Voyager Therapeutics' Interest & Investment Income had a median value of $2.4 million in 2025 and averaged $2.1 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first plummeted by 89382.72% in 2021, then surged by 591290.32% in 2023.
  • Quarter analysis of 5 years shows Voyager Therapeutics' Interest & Investment Income stood at -$643000.0 in 2021, then surged by 251.79% to $976000.0 in 2022, then soared by 223.16% to $3.2 million in 2023, then grew by 26.63% to $4.0 million in 2024, then crashed by 40.29% to $2.4 million in 2025.
  • Its Interest & Investment Income stands at $2.4 million for Q3 2025, versus $2.8 million for Q2 2025 and $3.3 million for Q1 2025.